Entry into a Material Definitive Agreement

Business Context and Reporting Period

This Form 8-K is a current report filed by Ekso Bionics Holdings, Inc. (not Chronoscale Holdings Corp) on September 29, 2023. The registrant is incorporated in Nevada and its common stock trades on the Nasdaq Capital Market under the symbol EKSO.

Key Financial Metrics

The filing does not provide comprehensive financial statements, revenue, profit, or cash flow data. However, it discloses a specific cash inflow:

  • Warranty Settlement: On September 25, 2023, the Company received $700,000 from Parker-Hannifin Corporation. This payment settled the Seller's obligation to reimburse the Company for costs and expenses related to certain product warranty obligations under a prior Asset Purchase Agreement.

Material Changes and Events

The filing reports two primary material events:

  1. Material Definitive Agreement (Item 1.01): Execution of a Warranty Claim Lump Summary Agreement resulting in the $700,000 payment described above.
  2. Nasdaq Delisting Notice (Item 3.01): The Company received notice from Nasdaq that its common stock failed to meet the $1.00 minimum bid price requirement for the last 30 consecutive business days.

Outlook, Risks, and Management Commentary

Compliance Timeline: The Company has been granted an initial 180-day compliance period ending March 27, 2024, to regain compliance with the minimum bid price requirement. Compliance is achieved if the closing bid price is $1.00 or more for 10 consecutive business days.

Contingencies and Risks:

  • If the Company fails to regain compliance by March 27, 2024, it may be eligible for an additional 180-day period if it meets other listing standards (e.g., market value of publicly held shares) and potentially effects a reverse stock split.
  • Failure to qualify for or meet requirements during the second period could result in delisting.
  • Management states there is no assurance that compliance will be regained or that Nasdaq will grant relief.

Forward-Looking Statements: The filing includes standard disclaimers regarding risks that actual results may differ from expectations, referencing the Company's 2023 Form 10-K for a full description of risks.

Investor Verification Checklist

  • Verify the current trading price of EKSO stock to assess proximity to the $1.00 threshold.
  • Monitor the Company's stock price performance over the next 10 consecutive business days to determine if the initial compliance period is met.
  • Review the Company's market value of publicly held shares to determine eligibility for a second compliance period if the first is missed.
  • Check for any announcements regarding a potential reverse stock split.
  • Confirm the impact of the $700,000 warranty settlement on the Company's cash position in subsequent quarterly reports.
Disclaimer:
This AI-generated summary by MetaQuotes is based on SEC filings and may contain errors. Verify important details against the original SEC filings.